Financhill
Sell
41

KNSA Quote, Financials, Valuation and Earnings

Last price:
$20.37
Seasonality move :
-9.83%
Day range:
$20.20 - $20.69
52-week range:
$16.56 - $28.15
Dividend yield:
0%
P/E ratio:
153.73x
P/S ratio:
3.90x
P/B ratio:
3.40x
Volume:
592.6K
Avg. volume:
291.8K
1-year change:
15.41%
Market cap:
$1.5B
Revenue:
$270.3M
EPS (TTM):
-$0.14

Earnings Data

Next earnings date for KNSA
Feb 28
2025
Most recent earnings per share
-$0.18
Missed by $0.25
(Oct 29/2024)
Consensus Estimate
$0.07
(Oct 29/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

KNSA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/28/2025 Q4 $123.2M -- -- $0.13 --
10/29/2024 Q3 $111.6M $112.2M -$0.18 $0.07 -$0.25
07/23/2024 Q2 $91.3M $108.6M -$0.06 $0.01 -$0.07
04/23/2024 Q1 $78.5M $79.9M -$0.25 -$0.08 -$0.17
02/28/2024 Q4 $72.3M $83.4M $0.35 -$0.09 $0.44
10/31/2023 Q3 -- -- -$0.20 -$0.16 -$0.04
07/25/2023 Q2 -- -- $0.21 -$0.13 $0.34
05/02/2023 Q1 -- -- -$0.18 -$0.17 -$0.02
02/28/2023 Q4 -- -- $0.06 -$0.14 $0.20
11/01/2022 Q3 -- -- $3.18 $0.83 $2.35
08/03/2022 Q2 -- -- -$0.29 -$0.39 $0.10
05/03/2022 Q1 -- -- -$0.36 -$0.26 -$0.10
02/22/2022 Q4 -- -- -$0.53 -$0.40 -$0.13
11/01/2021 Q3 -- -- -$0.44 -$0.63 $0.19
08/03/2021 Q2 -- -- -$0.61 -$0.78 $0.17
05/04/2021 Q1 -- -- -$0.72 -$0.63 -$0.09
02/23/2021 Q4 -- -- -$0.79 -$0.61 -$0.18
11/05/2020 Q3 -- -- -$0.66 -$0.59 -$0.07
07/30/2020 Q2 -- -- -$0.65 -$0.59 -$0.07
05/01/2020 Q1 -- -- -$0.48 -$0.62 $0.14
02/26/2020 Q4 -- -- -$0.58 -$0.76 $0.18
10/28/2019 Q3 -- -- -$0.49 -$0.70 $0.21
08/12/2019 Q2 -- -- -$0.68 -$0.76 $0.08
05/02/2019 Q1 -- -- -$0.73 -$0.79 $0.06
03/07/2019 Q4 -- -- -$0.88 -$0.74 -$0.14
11/01/2018 Q3 -- -- -$0.51 -$0.54 $0.03
08/06/2018 Q2 -- -- -$0.47 -$0.50 $0.03

Kiniksa Pharmaceuticals International PLC Earnings Questions

  • How Much did Kiniksa Pharmaceuticals International PLC Generate in Revenue Last Quarter?

    Kiniksa Pharmaceuticals International PLC reported $112.2M worth of top line sales in its most recent quarter.

  • Did Kiniksa Pharmaceuticals International PLC Beat Earnings Last Quarter?

    Kiniksa Pharmaceuticals International PLC announced earnings per share of -$0.18 which represents a miss of analyst forecast a $0.07 per share.

  • Is Kiniksa Pharmaceuticals International PLC Profitable?

    Kiniksa Pharmaceuticals International PLC reported $62.8M that represents $0.88 per share over the last quarter.

  • What is the Analyst Consensus for Kiniksa Pharmaceuticals International PLC EPS Next Year?

    Kiniksa Pharmaceuticals International PLC's earnings are forecast to decrease from $0.20 per share to -$0.40 per share next year representing a decrease of -5%.

  • When is Kiniksa Pharmaceuticals International PLC's Earnings Date?

    Kiniksa Pharmaceuticals International PLC's next earnings date is February 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 5.23% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 15.18% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.97% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock